Lifecore Biomedical (LFCR) Debt/Equity Ratio: History & Chart

Lifecore Biomedical, Inc.(LFCR)

Drug Manufacturers - Specialty & Generic · Chaska, MN

$6.50-0.02 (-0.27%)

Delayed quote: Oct 6, 2026, 10:25 AM EDT

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Chaska, MN

382 employees

www.lifecore.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Paul Josephs

View full financials

LFCR Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

9.64

DEBT TO EQUITY RATIO AVG TTM

4.01

DEBT TO EQUITY RATIO AVG 3Y

5.64

DEBT TO EQUITY RATIO AVG 5Y

4.01

DEBT TO EQUITY RATIO AVG 10Y

1.38

DEBT TO EQUITY RATIO AVG 15Y

0.50

DEBT TO EQUITY RATIO AVG 20Y

0.33

CURRENT VS TTM AVG

+140.11%

CURRENT VS 3Y AVG

+70.70%

CURRENT VS 5Y AVG

+140.33%

CURRENT VS 10Y AVG

+600.19%

CURRENT VS 15Y AVG

+1827.72%

CURRENT VS 20Y AVG

+2817.21%

SECTOR MEDIAN · HEALTHCARE

0.13

median of 531 covered companies

CURRENT VS SECTOR MEDIAN

+7312.11%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Lifecore Biomedical, Inc. (LFCR)	$243.91M	9.64	4.01	5.64	4.01
Greenwich LifeSciences, Inc. (GLSI)vs ›	$244.47M	0.00	0.00	0.00	0.00
CAMP4 Therapeutics Corporation (CAMP)vs ›	$243.47M	N/A	0.09	0.09	1.23
Invivyd, Inc. (IVVD)vs ›	$246.20M	0.05	0.01	0.01	0.01
InflaRx N.V. (IFRX)vs ›	$240.09M	0.01	0.01	0.01	0.01
Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›	$250.09M	0.03	0.06	0.07	0.04
High Tide Inc. (HITI)vs ›	$237.69M	1.17	1.11	0.80	1.37
Galectin Therapeutics Inc. (GALT)vs ›	$237.08M	N/A	5.55	2.78	1.85
Akebia Therapeutics, Inc. (AKBA)vs ›	$235.83M	2.16	6.63	12.85	7.19
BioAge Labs Inc. (BIOA)vs ›	$234.54M	0.01	0.03	0.03	0.03

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Lifecore Biomedical, Inc. (LFCR)

$243.91M

9.64

4.01

5.64

4.01

Greenwich LifeSciences, Inc. (GLSI)vs ›

$244.47M

0.00

CAMP4 Therapeutics Corporation (CAMP)vs ›

$243.47M

N/A

0.09

1.23

Invivyd, Inc. (IVVD)vs ›

$246.20M

0.05

0.01

InflaRx N.V. (IFRX)vs ›

$240.09M

0.01

Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›

$250.09M

0.03

0.06

0.07

0.04

High Tide Inc. (HITI)vs ›

$237.69M

1.17

1.11

0.80

1.37

Galectin Therapeutics Inc. (GALT)vs ›

$237.08M

N/A

5.55

2.78

1.85

Akebia Therapeutics, Inc. (AKBA)vs ›

$235.83M

2.16

6.63

12.85

7.19

BioAge Labs Inc. (BIOA)vs ›

$234.54M

0.01

0.03

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The debt to equity ratio for LFCR stock is 9.64.

Is Lifecore Biomedical, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 9.64 is 140% above its 5-year average of 4.01, around the middle of its 5-year range (-34.75–97.92).

What is the TTM average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The TTM average debt to equity ratio for LFCR stock is 4.01.

What is the 3Y average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The 3Y average debt to equity ratio for LFCR stock is 5.64.

What is the 5Y average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The 5Y average debt to equity ratio for LFCR stock is 4.01.

What is the 10Y average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The 10Y average debt to equity ratio for LFCR stock is 1.38.

What is the 15Y average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The 15Y average debt to equity ratio for LFCR stock is 0.50.

What is the 20Y average debt to equity ratio for Lifecore Biomedical, Inc. (LFCR)?

The 20Y average debt to equity ratio for LFCR stock is 0.33.

DATE	DEBT TO EQUITY RATIO
2026-06-30	-4.55
2026-06-30	9.64
2026-03-31	7.23
2025-09-30	3.74
2025-05-25	97.92
2025-02-23	58.48
2024-11-24	8.50
2024-08-25	-34.75
2024-05-26	11.81
2024-02-25	7.14
2023-11-26	2.84
2023-08-27	4.47
2023-05-28	-26.63
2023-02-26	3.71
2022-11-27	2.17
2022-08-28	1.62
2022-05-29	2.82
2022-02-28	0.94
2021-11-30	1.17
2021-08-31	0.91
2021-05-31	1.06
2021-02-28	1.05
2020-11-30	0.94
2020-08-31	0.91
2020-05-31	0.96
2020-02-29	0.83
2019-11-30	0.83
2019-08-31	0.75
2019-05-31	0.56
2019-02-28	0.54
2018-11-30	0.34
2018-08-31	0.33
2018-05-31	0.29
2018-02-28	0.24
2017-11-30	0.25
2017-08-31	0.26
2017-05-31	0.24
2017-02-28	0.23
2016-11-30	0.25
2016-08-31	0.26
2016-05-31	0.29
2016-02-29	0.30
2015-11-30	0.21
2015-08-31	0.18
2015-05-31	0.19
2015-02-28	0.23
2014-11-30	0.23
2014-08-31	0.19
2014-05-31	0.17
2014-02-28	0.18
2013-11-30	0.20
2013-08-31	0.22
2013-05-31	0.25
2013-02-28	0.27
2012-11-30	0.31
2012-08-31	0.35
2012-05-31	0.39
2012-02-29	0.11
2011-11-30	0.12
2011-08-31	0.13
2011-05-31	0.15
2011-02-28	0.15
2010-11-30	0.16
2010-08-31	0.17
2010-05-31	0.18
2010-02-28	0.00
2009-11-30	0.00
2009-08-31	0.00
2009-05-31	0.00
2009-02-28	0.00
2008-11-30	0.00
2008-08-31	0.00
2008-05-31	0.00
2008-02-29	0.00
2007-11-30	0.00
2007-08-31	0.00
2007-05-31	0.00
2007-02-28	0.00
2006-11-30	0.00
2006-08-31	0.00
2006-05-31	0.02
2006-02-28	0.03
2005-11-30	0.13
2005-08-31	0.03
2005-05-31	0.04
2005-02-28	0.06
2004-11-30	0.14
2004-08-31	0.16
2004-05-31	0.15
2004-02-29	0.18
2003-11-30	0.32
2003-08-31	0.22
2003-04-30	0.24
2003-01-31	0.26
2002-10-31	0.31
2002-07-31	0.29

DATE

DEBT TO EQUITY RATIO

2026-06-30

-4.55

2026-06-30

9.64

2026-03-31

7.23

2025-09-30

3.74

2025-05-25

97.92

2025-02-23

58.48

2024-11-24

8.50

2024-08-25

-34.75

2024-05-26

11.81

2024-02-25

7.14

2023-11-26

2.84

2023-08-27

4.47

2023-05-28

-26.63

2023-02-26

3.71

2022-11-27

2.17

2022-08-28

1.62

2022-05-29

2.82

2022-02-28

0.94

2021-11-30

1.17

2021-08-31

0.91

2021-05-31

1.06

2021-02-28

1.05

2020-11-30

0.94

2020-08-31

0.91

2020-05-31

0.96

2020-02-29

0.83

2019-11-30

0.83

2019-08-31

0.75

2019-05-31

0.56

2019-02-28

0.54

2018-11-30

0.34

2018-08-31

0.33

2018-05-31

0.29

2018-02-28

0.24

2017-11-30

0.25

2017-08-31

0.26

2017-05-31

0.24

2017-02-28

0.23

2016-11-30

0.25

2016-08-31

0.26

2016-05-31

0.29

2016-02-29

0.30

2015-11-30

0.21

2015-08-31

0.18

2015-05-31

0.19

2015-02-28

0.23

2014-11-30

0.23

2014-08-31

0.19

2014-05-31

0.17

2014-02-28

0.18

2013-11-30

0.20

2013-08-31

0.22

2013-05-31

0.25

2013-02-28

0.27

2012-11-30

0.31

2012-08-31

0.35

2012-05-31

0.39

2012-02-29

0.11

2011-11-30

0.12

2011-08-31

0.13

2011-05-31

0.15

2011-02-28

0.15

2010-11-30

0.16

2010-08-31

0.17

2010-05-31

0.18

2010-02-28

0.00

2009-11-30

0.00

2009-08-31

0.00

2009-05-31

0.00

2009-02-28

0.00

2008-11-30

0.00

2008-08-31

0.00

2008-05-31

0.00

2008-02-29

0.00

2007-11-30

0.00

2007-08-31

0.00

2007-05-31

0.00

2007-02-28

0.00

2006-11-30

0.00

2006-08-31

0.00

2006-05-31

0.02

2006-02-28

0.03

2005-11-30

0.13

2005-08-31

0.03

2005-05-31

0.04

2005-02-28

0.06

2004-11-30

0.14

2004-08-31

0.16

2004-05-31

0.15

2004-02-29

0.18

2003-11-30

0.32

2003-08-31

0.22

2003-04-30

0.24

2003-01-31

0.26

2002-10-31

0.31

2002-07-31

0.29

Debt to Equity Ratio: 9.64

LFCR Debt to Equity Ratio

LFCR Average Debt to Equity Ratio Chart

LFCR Current vs Average Debt to Equity Ratio Chart

LFCR Debt to Equity Ratio Metrics

LFCR Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

LFCR Debt to Equity Ratio History

Related Metrics